[Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].
Identifieur interne : 000040 ( Main/Exploration ); précédent : 000039; suivant : 000041[Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].
Auteurs : E. Redondo [Espagne] ; I. Rivero-Calle [Espagne] ; D A Vargas [Espagne] ; E. Mascar S [Espagne] ; J L Díaz-Maroto [Espagne] ; M. Linares [Espagne] ; A. Gil [Espagne] ; J. Molina [Espagne] ; I. Jimeno [Espagne] ; D. Oca A [Espagne] ; J E Yuste [Espagne] ; F. Martin N-Torres [Espagne]Source :
- Semergen [ 1578-8865 ]
Descripteurs français
- KwdFr :
- Adulte (MeSH), Espagne (MeSH), Grippe humaine (prévention et contrôle), Guides de bonnes pratiques cliniques comme sujet (MeSH), Humains (MeSH), Infections communautaires (prévention et contrôle), Pneumonie à pneumocoques (prévention et contrôle), Pneumonie à pneumocoques (épidémiologie), Vaccins antigrippaux (administration et posologie), Vaccins antipneumococciques (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux, Vaccins antipneumococciques.
- prévention et contrôle : Grippe humaine, Infections communautaires, Pneumonie à pneumocoques.
- épidémiologie : Pneumonie à pneumocoques.
- Adulte, Espagne, Guides de bonnes pratiques cliniques comme sujet, Humains.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adult (MeSH), Community-Acquired Infections (prevention & control), Humans (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (prevention & control), Pneumococcal Vaccines (administration & dosage), Pneumonia, Pneumococcal (epidemiology), Pneumonia, Pneumococcal (prevention & control), Practice Guidelines as Topic (MeSH), Spain (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines, Pneumococcal Vaccines.
- geographic : Spain.
- epidemiology : Pneumonia, Pneumococcal.
- prevention & control : Community-Acquired Infections, Influenza, Human, Pneumonia, Pneumococcal.
- Adult, Humans, Practice Guidelines as Topic.
Abstract
Community-acquired pneumonia (CAP) continues to be an important cause of morbidity and mortality in adults. The aim of this study is to update the 2016 practical prevention guidelines for CAP through vaccination in Spain, based on the available vaccines, as well as the evidence using a literature review and expert opinion. Vaccines against pneumococcus and influenza continue to be the main prevention tools available against CAP, and can contribute to reduce the burden of disease due to CAP and its associated complications. The available evidence supports the priority indications established in these guidelines, and it would be advisable to try to achieve a widespread dissemination and implementation of these recommendations in routine clinical practice.
DOI: 10.1016/j.semerg.2018.09.005
PubMed: 30318406
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].</title><author><name sortKey="Redondo, E" sort="Redondo, E" uniqKey="Redondo E" first="E" last="Redondo">E. Redondo</name><affiliation wicri:level="3"><nlm:affiliation>Grupo de Actividades Preventivas y Salud Pública SEMERGEN. Centro de Salud Internacional Ayuntamiento de Madrid, Madrid, España. Electronic address: redondome@madrid.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Grupo de Actividades Preventivas y Salud Pública SEMERGEN. Centro de Salud Internacional Ayuntamiento de Madrid, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Rivero Calle, I" sort="Rivero Calle, I" uniqKey="Rivero Calle I" first="I" last="Rivero-Calle">I. Rivero-Calle</name><affiliation wicri:level="1"><nlm:affiliation>Sección de Pediatría Clínica, Infectológica y Traslacional, Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Genética, Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, La Coruña, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Sección de Pediatría Clínica, Infectológica y Traslacional, Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Genética, Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, La Coruña</wicri:regionArea><wicri:noRegion>La Coruña</wicri:noRegion></affiliation></author><author><name sortKey="Vargas, D A" sort="Vargas, D A" uniqKey="Vargas D" first="D A" last="Vargas">D A Vargas</name><affiliation wicri:level="1"><nlm:affiliation>Unidad de Hospitalización Versátil, Hospital de Alta Resolución El Toyo. Agencia Pública Sanitaria, Hospital de Poniente, Almería, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unidad de Hospitalización Versátil, Hospital de Alta Resolución El Toyo. Agencia Pública Sanitaria, Hospital de Poniente, Almería</wicri:regionArea><wicri:noRegion>Almería</wicri:noRegion></affiliation></author><author><name sortKey="Mascar S, E" sort="Mascar S, E" uniqKey="Mascar S E" first="E" last="Mascar S">E. Mascar S</name><affiliation wicri:level="1"><nlm:affiliation>Departamento de Salud Dr. Peset, Centro de Atención Primaria Fuente de San Luís, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento de Salud Dr. Peset, Centro de Atención Primaria Fuente de San Luís, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Diaz Maroto, J L" sort="Diaz Maroto, J L" uniqKey="Diaz Maroto J" first="J L" last="Díaz-Maroto">J L Díaz-Maroto</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Atención Primaria de Guadalajara, Guadalajara, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Atención Primaria de Guadalajara, Guadalajara</wicri:regionArea><wicri:noRegion>Guadalajara</wicri:noRegion></affiliation></author><author><name sortKey="Linares, M" sort="Linares, M" uniqKey="Linares M" first="M" last="Linares">M. Linares</name><affiliation wicri:level="3"><nlm:affiliation>Grupo de Enfermedades Infecciosas de SEMERGEN, Fundación io, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Grupo de Enfermedades Infecciosas de SEMERGEN, Fundación io, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Gil, A" sort="Gil, A" uniqKey="Gil A" first="A" last="Gil">A. Gil</name><affiliation wicri:level="3"><nlm:affiliation>Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Molina, J" sort="Molina, J" uniqKey="Molina J" first="J" last="Molina">J. Molina</name><affiliation wicri:level="3"><nlm:affiliation>Centro de Atención Primaria Francia, Fuenlabrada, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Atención Primaria Francia, Fuenlabrada, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Jimeno, I" sort="Jimeno, I" uniqKey="Jimeno I" first="I" last="Jimeno">I. Jimeno</name><affiliation wicri:level="3"><nlm:affiliation>Centro de salud Isla de Oza, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de salud Isla de Oza, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Oca A, D" sort="Oca A, D" uniqKey="Oca A D" first="D" last="Oca A">D. Oca A</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Atención Primaria Algeciras-Norte, Algeciras, Cádiz, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Atención Primaria Algeciras-Norte, Algeciras, Cádiz</wicri:regionArea><wicri:noRegion>Cádiz</wicri:noRegion></affiliation></author><author><name sortKey="Yuste, J E" sort="Yuste, J E" uniqKey="Yuste J" first="J E" last="Yuste">J E Yuste</name><affiliation wicri:level="3"><nlm:affiliation>Centro Nacional de Microbiología, Instituto de Salud Carlos III y CIBER de Enfermedades Respiratorias (CIBERES), Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro Nacional de Microbiología, Instituto de Salud Carlos III y CIBER de Enfermedades Respiratorias (CIBERES), Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Martin N Torres, F" sort="Martin N Torres, F" uniqKey="Martin N Torres F" first="F" last="Martin N-Torres">F. Martin N-Torres</name><affiliation wicri:level="1"><nlm:affiliation>Sección de Pediatría Clínica, Infectológica y Traslacional, Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Genética, Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, La Coruña, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Sección de Pediatría Clínica, Infectológica y Traslacional, Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Genética, Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, La Coruña</wicri:regionArea><wicri:noRegion>La Coruña</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018 Nov - Dec</date><idno type="RBID">pubmed:30318406</idno><idno type="pmid">30318406</idno><idno type="doi">10.1016/j.semerg.2018.09.005</idno><idno type="wicri:Area/Main/Corpus">00039</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00039</idno><idno type="wicri:Area/Main/Curation">000039</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000039</idno><idno type="wicri:Area/Main/Exploration">000039</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].</title><author><name sortKey="Redondo, E" sort="Redondo, E" uniqKey="Redondo E" first="E" last="Redondo">E. Redondo</name><affiliation wicri:level="3"><nlm:affiliation>Grupo de Actividades Preventivas y Salud Pública SEMERGEN. Centro de Salud Internacional Ayuntamiento de Madrid, Madrid, España. Electronic address: redondome@madrid.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Grupo de Actividades Preventivas y Salud Pública SEMERGEN. Centro de Salud Internacional Ayuntamiento de Madrid, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Rivero Calle, I" sort="Rivero Calle, I" uniqKey="Rivero Calle I" first="I" last="Rivero-Calle">I. Rivero-Calle</name><affiliation wicri:level="1"><nlm:affiliation>Sección de Pediatría Clínica, Infectológica y Traslacional, Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Genética, Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, La Coruña, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Sección de Pediatría Clínica, Infectológica y Traslacional, Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Genética, Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, La Coruña</wicri:regionArea><wicri:noRegion>La Coruña</wicri:noRegion></affiliation></author><author><name sortKey="Vargas, D A" sort="Vargas, D A" uniqKey="Vargas D" first="D A" last="Vargas">D A Vargas</name><affiliation wicri:level="1"><nlm:affiliation>Unidad de Hospitalización Versátil, Hospital de Alta Resolución El Toyo. Agencia Pública Sanitaria, Hospital de Poniente, Almería, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unidad de Hospitalización Versátil, Hospital de Alta Resolución El Toyo. Agencia Pública Sanitaria, Hospital de Poniente, Almería</wicri:regionArea><wicri:noRegion>Almería</wicri:noRegion></affiliation></author><author><name sortKey="Mascar S, E" sort="Mascar S, E" uniqKey="Mascar S E" first="E" last="Mascar S">E. Mascar S</name><affiliation wicri:level="1"><nlm:affiliation>Departamento de Salud Dr. Peset, Centro de Atención Primaria Fuente de San Luís, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento de Salud Dr. Peset, Centro de Atención Primaria Fuente de San Luís, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Diaz Maroto, J L" sort="Diaz Maroto, J L" uniqKey="Diaz Maroto J" first="J L" last="Díaz-Maroto">J L Díaz-Maroto</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Atención Primaria de Guadalajara, Guadalajara, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Atención Primaria de Guadalajara, Guadalajara</wicri:regionArea><wicri:noRegion>Guadalajara</wicri:noRegion></affiliation></author><author><name sortKey="Linares, M" sort="Linares, M" uniqKey="Linares M" first="M" last="Linares">M. Linares</name><affiliation wicri:level="3"><nlm:affiliation>Grupo de Enfermedades Infecciosas de SEMERGEN, Fundación io, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Grupo de Enfermedades Infecciosas de SEMERGEN, Fundación io, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Gil, A" sort="Gil, A" uniqKey="Gil A" first="A" last="Gil">A. Gil</name><affiliation wicri:level="3"><nlm:affiliation>Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Molina, J" sort="Molina, J" uniqKey="Molina J" first="J" last="Molina">J. Molina</name><affiliation wicri:level="3"><nlm:affiliation>Centro de Atención Primaria Francia, Fuenlabrada, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Atención Primaria Francia, Fuenlabrada, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Jimeno, I" sort="Jimeno, I" uniqKey="Jimeno I" first="I" last="Jimeno">I. Jimeno</name><affiliation wicri:level="3"><nlm:affiliation>Centro de salud Isla de Oza, Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de salud Isla de Oza, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Oca A, D" sort="Oca A, D" uniqKey="Oca A D" first="D" last="Oca A">D. Oca A</name><affiliation wicri:level="1"><nlm:affiliation>Centro de Atención Primaria Algeciras-Norte, Algeciras, Cádiz, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro de Atención Primaria Algeciras-Norte, Algeciras, Cádiz</wicri:regionArea><wicri:noRegion>Cádiz</wicri:noRegion></affiliation></author><author><name sortKey="Yuste, J E" sort="Yuste, J E" uniqKey="Yuste J" first="J E" last="Yuste">J E Yuste</name><affiliation wicri:level="3"><nlm:affiliation>Centro Nacional de Microbiología, Instituto de Salud Carlos III y CIBER de Enfermedades Respiratorias (CIBERES), Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centro Nacional de Microbiología, Instituto de Salud Carlos III y CIBER de Enfermedades Respiratorias (CIBERES), Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Martin N Torres, F" sort="Martin N Torres, F" uniqKey="Martin N Torres F" first="F" last="Martin N-Torres">F. Martin N-Torres</name><affiliation wicri:level="1"><nlm:affiliation>Sección de Pediatría Clínica, Infectológica y Traslacional, Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Genética, Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, La Coruña, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Sección de Pediatría Clínica, Infectológica y Traslacional, Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Genética, Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, La Coruña</wicri:regionArea><wicri:noRegion>La Coruña</wicri:noRegion></affiliation></author></analytic><series><title level="j">Semergen</title><idno type="eISSN">1578-8865</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Community-Acquired Infections (prevention & control)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (prevention & control)</term><term>Pneumococcal Vaccines (administration & dosage)</term><term>Pneumonia, Pneumococcal (epidemiology)</term><term>Pneumonia, Pneumococcal (prevention & control)</term><term>Practice Guidelines as Topic (MeSH)</term><term>Spain (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Espagne (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Guides de bonnes pratiques cliniques comme sujet (MeSH)</term><term>Humains (MeSH)</term><term>Infections communautaires (prévention et contrôle)</term><term>Pneumonie à pneumocoques (prévention et contrôle)</term><term>Pneumonie à pneumocoques (épidémiologie)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antipneumococciques (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term><term>Pneumococcal Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins antipneumococciques</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Pneumonia, Pneumococcal</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Community-Acquired Infections</term><term>Influenza, Human</term><term>Pneumonia, Pneumococcal</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term><term>Infections communautaires</term><term>Pneumonie à pneumocoques</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Pneumonie à pneumocoques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Humans</term><term>Practice Guidelines as Topic</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Espagne</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Community-acquired pneumonia (CAP) continues to be an important cause of morbidity and mortality in adults. The aim of this study is to update the 2016 practical prevention guidelines for CAP through vaccination in Spain, based on the available vaccines, as well as the evidence using a literature review and expert opinion. Vaccines against pneumococcus and influenza continue to be the main prevention tools available against CAP, and can contribute to reduce the burden of disease due to CAP and its associated complications. The available evidence supports the priority indications established in these guidelines, and it would be advisable to try to achieve a widespread dissemination and implementation of these recommendations in routine clinical practice.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30318406</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-8865</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>8</Issue><PubDate><MedlineDate>2018 Nov - Dec</MedlineDate></PubDate></JournalIssue><Title>Semergen</Title><ISOAbbreviation>Semergen</ISOAbbreviation></Journal><ArticleTitle>[Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].</ArticleTitle><Pagination><MedlinePgn>590-597</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1138-3593(18)30367-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semerg.2018.09.005</ELocationID><Abstract><AbstractText>Community-acquired pneumonia (CAP) continues to be an important cause of morbidity and mortality in adults. The aim of this study is to update the 2016 practical prevention guidelines for CAP through vaccination in Spain, based on the available vaccines, as well as the evidence using a literature review and expert opinion. Vaccines against pneumococcus and influenza continue to be the main prevention tools available against CAP, and can contribute to reduce the burden of disease due to CAP and its associated complications. The available evidence supports the priority indications established in these guidelines, and it would be advisable to try to achieve a widespread dissemination and implementation of these recommendations in routine clinical practice.</AbstractText><CopyrightInformation>Copyright © 2018 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Redondo</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Grupo de Actividades Preventivas y Salud Pública SEMERGEN. Centro de Salud Internacional Ayuntamiento de Madrid, Madrid, España. Electronic address: redondome@madrid.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivero-Calle</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sección de Pediatría Clínica, Infectológica y Traslacional, Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Genética, Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, La Coruña, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>D A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Unidad de Hospitalización Versátil, Hospital de Alta Resolución El Toyo. Agencia Pública Sanitaria, Hospital de Poniente, Almería, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mascarós</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Salud Dr. Peset, Centro de Atención Primaria Fuente de San Luís, Valencia, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Díaz-Maroto</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Centro de Atención Primaria de Guadalajara, Guadalajara, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linares</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Grupo de Enfermedades Infecciosas de SEMERGEN, Fundación io, Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medicina Preventiva y Salud Pública, Universidad Rey Juan Carlos, Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro de Atención Primaria Francia, Fuenlabrada, Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimeno</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centro de salud Isla de Oza, Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ocaña</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centro de Atención Primaria Algeciras-Norte, Algeciras, Cádiz, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuste</LastName><ForeName>J E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Centro Nacional de Microbiología, Instituto de Salud Carlos III y CIBER de Enfermedades Respiratorias (CIBERES), Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinón-Torres</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sección de Pediatría Clínica, Infectológica y Traslacional, Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, España; Genética, Vacunas e Infecciones Pediátricas (GENVIP), Instituto de Investigación de Santiago, Santiago de Compostela, La Coruña, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>en nombre de Neumoexpertos en Prevención</CollectiveName></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Vacunación frente a la neumonía adquirida en la comunidad del adulto. Actualización 2018 del posicionamiento del Grupo de Neumoexpertos en Prevención.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Semergen</MedlineTA><NlmUniqueID>9610769</NlmUniqueID><ISSNLinking>1138-3593</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011018" MajorTopicYN="N">Pneumonia, Pneumococcal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Community-acquired pneumonia</Keyword><Keyword MajorTopicYN="N">Influenza vaccination</Keyword><Keyword MajorTopicYN="N">Neumonía adquirida en la comunidad</Keyword><Keyword MajorTopicYN="N">Pneumococcal conjugate vaccine</Keyword><Keyword MajorTopicYN="N">Pneumococcal polysaccharide vaccine</Keyword><Keyword MajorTopicYN="N">Vacuna antineumocócica conjugada</Keyword><Keyword MajorTopicYN="N">Vacuna antineumocócica polisacárida</Keyword><Keyword MajorTopicYN="N">Vacunación antigripal</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>09</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30318406</ArticleId><ArticleId IdType="pii">S1138-3593(18)30367-8</ArticleId><ArticleId IdType="doi">10.1016/j.semerg.2018.09.005</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Communauté de Madrid</li></region><settlement><li>Madrid</li></settlement></list><tree><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Redondo, E" sort="Redondo, E" uniqKey="Redondo E" first="E" last="Redondo">E. Redondo</name></region><name sortKey="Diaz Maroto, J L" sort="Diaz Maroto, J L" uniqKey="Diaz Maroto J" first="J L" last="Díaz-Maroto">J L Díaz-Maroto</name><name sortKey="Gil, A" sort="Gil, A" uniqKey="Gil A" first="A" last="Gil">A. Gil</name><name sortKey="Jimeno, I" sort="Jimeno, I" uniqKey="Jimeno I" first="I" last="Jimeno">I. Jimeno</name><name sortKey="Linares, M" sort="Linares, M" uniqKey="Linares M" first="M" last="Linares">M. Linares</name><name sortKey="Martin N Torres, F" sort="Martin N Torres, F" uniqKey="Martin N Torres F" first="F" last="Martin N-Torres">F. Martin N-Torres</name><name sortKey="Mascar S, E" sort="Mascar S, E" uniqKey="Mascar S E" first="E" last="Mascar S">E. Mascar S</name><name sortKey="Molina, J" sort="Molina, J" uniqKey="Molina J" first="J" last="Molina">J. Molina</name><name sortKey="Oca A, D" sort="Oca A, D" uniqKey="Oca A D" first="D" last="Oca A">D. Oca A</name><name sortKey="Rivero Calle, I" sort="Rivero Calle, I" uniqKey="Rivero Calle I" first="I" last="Rivero-Calle">I. Rivero-Calle</name><name sortKey="Vargas, D A" sort="Vargas, D A" uniqKey="Vargas D" first="D A" last="Vargas">D A Vargas</name><name sortKey="Yuste, J E" sort="Yuste, J E" uniqKey="Yuste J" first="J E" last="Yuste">J E Yuste</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000040 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000040 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:30318406
|texte= [Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:30318406" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |